#2 - Jiangbo Pharmaceuticals (JGBO)Recommended by: Robert Hsu, editor of Asia Edge
Return for August: +8% vs. -4% for the Dow Jones
Founded in 2003, Jiangbo Pharmaceuticals (JGBO) is a leader in drug development and manufacturing in China. The acquisition of competitor Hongrui in January 2009 increased Jiangbo's product portfolio from six to 28, and the company has recently received the final approval for production of its new Felodipine Sustained Release Tablets. The launch of this medication is expected to add 10% to 12% in forward sales.